ORCHID CELLMARK INC|4Dec 19, 4:53 PM ET

ORCHID CELLMARK INC 4

4 · ORCHID CELLMARK INC · Filed Dec 19, 2011

Form 4

Period: 2011-12-15

DirectorPresident and CEO

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−170,000$476,000→ 0 total
Exercise: $1.64Exp: 2020-05-26→ Common Stock (170,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−145,000$406,000→ 0 total
Exercise: $3.03Exp: 2018-06-05→ Common Stock (145,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−600,000$1,680,000→ 0 total
Exercise: $4.53Exp: 2016-04-25→ Common Stock (600,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2011-12-15$2.80/sh−170,000$476,000→ 0 total
Exercise: $1.54Exp: 2019-06-25→ Common Stock (170,000 underlying)

Footnotes (3)

[F1]This option was cancelled pursuant to the Agreement and Plan of Merger between Laboratory Corporation of America Holdings, OCM Acquisition Corp. and Orchid Cellmark Inc., dated as of April 5, 2011, as amended (the "Merger Agreement"). The reporting person did not receive any consideration for the cancellation because the exercise price of the options was more than the offer price ($2.80 per share).
[F2]This option was cancelled in exchange for a cash payment of $214,200, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Merger Agreement.
[F3]This option was cancelled in exchange for a cash payment of $197,200, representing the difference between the exercise price of the option and the offer price ($2.80 per share) pursuant to the Merger Agreement.

Documents

1 file